hematologic malignancies
Genomic Testing Cooperative Gets UKCA Marks for Cancer Assays
The UK Conformity Assessed marking covers the company's sequencing-based assays for solid tumors and hematologic neoplasms.
Tempus, IFLI Partner to Accelerate Development of Follicular Lymphoma Therapies
The collaboration will involve making a real-world multimodal dataset available in Tempus' Lens platform that researchers can use to accelerate treatment development.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
Genomic Study Suggests Treatment Target for Preleukemic Platelet Disorder Condition
Researchers narrowed in on a potentially targetable pathway containing the macrophage migration inhibitory factor receptor CD74.
Pathologists See Value Balance Shift Toward Comprehensive Sequencing for Hematologic Cancers
Premium
At the AMP annual meeting last week, speakers at multiple workshops said their field is reaching a tipping point as the clinical utility of NGS further solidifies.
Nov 18, 2024
Jan 17, 2024
Apr 26, 2023